Australia · Delayed Price · Currency is AUD ReNerve Company Description
ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures in New Zealand and the United States.
It develops Nerve Cuff, a bioabsorbable protective wrap used to protect repaired nerves; and Nerve Graft, an off-the-shelf nerve grafts for the repair of damaged nerves under the NervAlign brand.
The company also offers Empliq Dermal, an acellular dermal matrix (ADM) sourced from donated human skin and designed to replace lost or damaged dermal tissue; bionic nerve, a novel combination polymer technology; and Nerve Guide Matrix for treating more severe nerve injuries but eliminating the need for patients to undergo additional sural nerve harvesting under the NervAlign brand.
The company was incorporated in 2016 and is headquartered in Northcote, Australia.
| Country | Australia |
| Founded | 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Julian Chick |
Contact Details
Address: 157 Heidelberg Road Northcote, VIC 3070 Australia | |
| Phone | 61 3 9482 3940 |
| Website | renerve.com.au |
Stock Details
| Ticker Symbol | RNV |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Dr. Julian John Chick BSc (Hons) | Chief Executive Officer and Executive Director |
| Dr. David Ian Rhodes | CSO and Executive Director |
| David Lilja CTA, M.B.A. | Chief Financial Officer and Company Secretary |
| Dr. Alex Adamides FRACS, M.D. | Chief Medical Officer and Member of Scientific Advisory Board |